This refresh
Data-driven refresh May 29, 2026. Top 5 per bucket by live Bull Rankings score across a 5181-ticker universe covering every US-listed common stock on NYSE, NASDAQ, NYSE American, and NYSE Arca (2545 passed the market-cap / liquidity screen). Fundamentals sourced from Yahoo Finance quoteSummary + quarterly FCF reconstruction; narrative authored by Groq (with Gemini and data-driven fallbacks). Intraday re-ranking from a top-30 per-bucket shortlist.
Growth — high-quality compounders
1. KGC — Kinross Gold Corporation · score 99
Gold · price $30.18 · 1Y $40.95 · 5Y $48.61 · 10Y $71.45
FCF $3.0b B · Rev +36.9% A · D/E 0.08 A- · P/E 12.8x A- · PEG 1.12 B+
Why now. Kinross Gold Corporation, a mid-cap gold miner, is poised for growth driven by its 36.9% revenue growth rate and 12.8 P/E ratio, which is reasonable considering its 36% profit margin. With a current price of $30.18 and an analyst consensus 1-yr target of $40.95, the setup is attractive. The company's $3.0b in free cash flow and 35.5% ROE suggest a strong underlying business.
Moat. Kinross Gold Corporation's moat stems from its ability to generate high returns on equity, with an 35.5% ROE driven by its 36% profit margin. This is likely due to its position in the gold sector, where companies with strong production profiles can command premium prices. The company's 4.5 PS ratio and 1.12 PEG ratio also suggest a reasonable valuation relative to its growth prospects.
Risk. The main risks facing Kinross Gold Corporation include its 1.37 beta, which indicates a higher level of volatility, and its 0.08 debt-to-equity ratio, which is relatively low but could still pose a risk if interest rates rise. Additionally, the company's 12.8 P/E ratio is not extremely low, which could make it vulnerable to multiple compression if growth slows.
Horizon. 1-3 yr $40.95 (analyst consensus (n=11)) — fundamentals + valuation re-rating. 5 yr $48.61 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $71.45 if current growth sustains into durable earnings power.
2. FSM — Fortuna Mining Corp. · score 97
Gold · price $10.06 · 1Y $11.57 · 5Y $16.20 · 10Y $23.82
FCF $563m C+ · Rev +39.8% A · D/E 0.11 A- · P/E 9.3x A · PEG n/a
Why now. Fortuna Mining Corp., a gold sector growth company, is currently trading at a $10.06 price with a 9.3 P/E ratio, indicating a relatively low valuation. The company has demonstrated a 39.8% revenue growth rate, driven by its position in the gold sector. With an analyst consensus target of $14, there is potential for upside.
Moat. Fortuna Mining Corp.'s 22% ROE can be attributed to its pricing power as a mid-cap precious-metals miner with diversified production geographies. The company's 31.1% profit margin suggests a strong ability to maintain its competitive position. Its 2.8 P/S ratio indicates a reasonable valuation relative to its sales.
Risk. The company's 2.09 beta indicates a higher volatility compared to the overall market. Additionally, the 0.11 debt-to-equity ratio, although relatively low, still poses a risk if the company's cash flow were to decline. The 39.8% revenue growth rate may also be subject to fluctuations in the gold sector, posing a risk to the company's growth prospects.
Horizon. 1-3 yr $11.57 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $16.20 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $23.82 if current growth sustains into durable earnings power.
3. PICS — PicS N.V. · score 97
Software - Infrastructure · price $10.59 · 1Y $22.21 · 5Y $17.06 · 10Y $25.07
FCF $168m C · Rev +65.0% A · D/E 0.41 B · P/E 6.3x A · PEG n/a
Why now. PicS N.V., a software infrastructure company, is currently trading at a $10.59 price point with a 6.3 P/E ratio, which is relatively low considering its 65% revenue growth rate. The company's free cash flow of $168m and profit margin of 10.6% demonstrate its ability to generate cash and maintain profitability. With an analyst consensus 1-yr target of $22.21, there is potential for significant upside.
Moat. PicS N.V.'s return on equity of 40.4% can be attributed to its ability to maintain a high level of profitability in the software infrastructure sector. The company's debt-to-equity ratio of 0.41 indicates a manageable level of debt, allowing it to invest in growth initiatives. Its position in the software infrastructure sector provides a moat, as companies in this sector often have high switching costs and network effects, making it difficult for customers to switch to competitors.
Risk. One of the material risks facing PicS N.V. is its reliance on high revenue growth, with a 65% growth rate that may be difficult to sustain. Additionally, the company's 0.41 debt-to-equity ratio, while manageable, still poses a risk if interest rates rise or the company's cash flow decreases. Furthermore, the lack of a PEG ratio due to unavailable forward EPS estimates makes it challenging to assess the company's valuation relative to its growth prospects.
Horizon. 1-3 yr $22.21 (analyst consensus (n=9)) — fundamentals + valuation re-rating. 5 yr $17.06 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $25.07 if current growth sustains into durable earnings power.
4. DLO — DLocal Limited · score 96
Software - Infrastructure · price $11.86 · 1Y $17.35 · 5Y $19.10 · 10Y $28.08
FCF $374m C · Rev +46.6% A · D/E 0.20 B+ · P/E 18.5x B+ · PEG n/a
Why now. DLocal Limited, a software infrastructure company, is currently trading at $11.86 with a P/E of 18.5, which is reasonable given its 46.6% revenue growth rate and 15.8% profit margin. The company's free cash flow of $374m and return on equity of 35% demonstrate its ability to generate strong cash flows and high returns on investment. With an analyst consensus 1-yr target of $17.35, there is potential for upside.
Moat. DLocal's moat is driven by its high return on equity of 35%, which is a result of its 15.8% profit margin and efficient use of capital. The company's 2.9 price-to-sales ratio is also a testament to its strong business model and sector economics. Additionally, its low debt-to-equity ratio of 0.2 provides flexibility for future investments and growth initiatives.
Risk. One of the key risks facing DLocal is its high beta of 1.02, which indicates that the stock may be more volatile than the overall market. Additionally, the company's debt-to-equity ratio of 0.2 is relatively low, but any increase in debt levels could pose a risk to the company's financial health. Furthermore, the company's reliance on a few key customers or markets could also pose a risk to its revenue growth and profitability.
Horizon. 1-3 yr $17.35 (analyst consensus (n=10)) — fundamentals + valuation re-rating. 5 yr $19.10 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $28.08 if current growth sustains into durable earnings power.
5. ACN — Accenture plc · score 95
Information Technology Services · price $187.07 · 1Y $247.55 · 5Y $301.28 · 10Y $442.86
FCF $12.5b A- · Rev +7.4% B · D/E 0.25 B · P/E 15.3x A- · PEG 1.25 B
Why now. Accenture plc, a leading Information Technology Services provider, is currently trading at a $187.07 price with a 15.3 P/E ratio, indicating a reasonable valuation. The company's 7.4% revenue growth rate and 10.6% profit margin suggest a strong growth trajectory. With an analyst consensus 1-yr target of $247.55, the stock has potential for upside driven by its growth rate and $12.5B in free cash flow.
Moat. Accenture's durable competitive advantage stems from its high 24.8% ROE, driven by its pricing power in the IT services sector. The company's 1.6 PS ratio and 1.25 PEG ratio indicate a strong business model with efficient operations. Its low 0.25 debt-to-equity ratio also provides flexibility for future investments and expansions.
Risk. The main risks for Accenture include its 1.07 beta, indicating higher volatility, and the potential for revenue deceleration. Additionally, the company's $115.1B market cap and 15.3 P/E ratio may be considered elevated, leaving limited room for error. Regulatory changes in the IT services sector could also impact the company's operations and profitability.
Horizon. 1-3 yr $247.55 (analyst consensus (n=26)) — fundamentals + valuation re-rating. 5 yr $301.28 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $442.86 if current growth sustains into durable earnings power.
Value — quality at a discount
1. AU — AngloGold Ashanti plc · score 101
Gold · price $96.84 · 1Y $123.29 · 5Y $129.59 · 10Y $165.42
FCF $4.2b B · Rev +70.8% A · D/E 0.22 B+ · P/E 14.2x A- · PEG 0.78 A-
Why now. AngloGold Ashanti plc, a mid-cap gold miner, trades at a 14.2 P/E with a 0.78 PEG ratio, indicating undervaluation given its 70.8% revenue growth rate. The company sells gold to various end markets, with a current price of $96.84 and an analyst consensus 1-yr target of $123.29. The re-rating catalyst could be the company's high 43% ROE and 31.1% profit margin, which may attract investors seeking value in the gold sector.
Moat. AngloGold Ashanti's moat stems from its diversified production geographies and low 0.22 debt-to-equity ratio, allowing for flexibility in capital allocation. The company's high 43% ROE can be attributed to its 31.1% profit margin, driven by its ability to maintain low costs and generate significant free cash flow of $4.2B. This enables the company to invest in its operations and return value to shareholders.
Risk. The main risks facing AngloGold Ashanti include the 0.62 beta, indicating moderate volatility, and the potential for a decline in gold prices, which could impact revenue. Additionally, the company's 14.2 P/E may be elevated compared to its peers, and a decrease in profit margin could negatively impact the stock price. Regulatory risks, such as changes in mining regulations, could also affect the company's operations.
Horizon. 1-3 yr $123.29 (analyst consensus (n=7)) — multiple re-rating thesis requires a catalyst. 5 yr $129.59 at ~6% CAGR — dividend + buyback compounding. 10 yr $165.42 if the moat survives secular pressure.
2. PDD — PDD Holdings Inc. · score 100
Internet Retail · price $84.44 · 1Y $124.36 · 5Y $113.00 · 10Y $144.24
FCF $15.8b A- · Rev +9.7% B · D/E 0.01 A · P/E 8.9x A · PEG 0.62 A-
Why now. PDD Holdings Inc., an internet retail company, presents a compelling value proposition with its current price of $84.44, a P/E of 8.9, and a 21.6% profit margin. The company's $15.8B in free cash flow and 25.4% ROE indicate a strong financial foundation. With an analyst consensus 1-yr target of $124.36, there is potential for significant upside.
Moat. PDD's durable competitive advantage stems from its ability to generate a 25.4% ROE, driven by its 21.6% profit margin and efficient operations. The company's low debt-to-equity ratio of 0.01 and significant free cash flow provide a solid foundation for long-term growth. Additionally, its 9.7% revenue growth rate suggests a strong market position.
Risk. PDD faces risks related to its low beta of 0.03, which may indicate a lack of volatility, but also potentially limited upside. The company's 1.8 price-to-sales ratio is relatively low, which may not provide a significant margin of safety. Furthermore, the 0.62 PEG ratio suggests that the stock may be undervalued, but also potentially vulnerable to changes in growth expectations.
Horizon. 1-3 yr $124.36 (analyst consensus (n=33)) — multiple re-rating thesis requires a catalyst. 5 yr $113.00 at ~6% CAGR — dividend + buyback compounding. 10 yr $144.24 if the moat survives secular pressure.
3. INCY — Incyte Corporation · score 99
Biotechnology · price $96.74 · 1Y $107.96 · 5Y $129.46 · 10Y $165.25
FCF $1.4b C+ · Rev +21.2% A- · D/E 0.01 A · P/E 13.7x A- · PEG 0.36 A
Why now. Incyte Corporation, a biotechnology company, is undervalued given its strong fundamentals, with a current price of $96.74, a P/E of 13.7, and a revenue growth rate of 21.2%. The company's profit margin of 26.7% and ROE of 30.8% demonstrate its ability to generate earnings. With an analyst consensus 1-yr target of $107.96, there is potential for re-rating.
Moat. Incyte's moat is driven by its ability to generate strong free cash flow, with $1.4B in FCF over the last twelve months, and its low debt-to-equity ratio of 0.01. The company's beta of 0.8 indicates a relatively stable stock price, and its price-to-sales ratio of 3.6 suggests that it is reasonably valued. The company's strong ROE is attributed to its pricing power in the biotechnology sector.
Risk. The main risks facing Incyte Corporation are its dependence on a few key products, the potential for regulatory changes, and the debt-to-equity ratio creeping up from its current level of 0.01. Additionally, the company's P/E of 13.7 is relatively low, which may indicate that the stock is undervalued, but also leaves room for potential downside if the company's growth rate slows. The analyst recommendation mean of 2.39 indicates a buy rating, but there is always a risk that analyst expectations may not be met.
Horizon. 1-3 yr $107.96 (analyst consensus (n=24)) — multiple re-rating thesis requires a catalyst. 5 yr $129.46 at ~6% CAGR — dividend + buyback compounding. 10 yr $165.25 if the moat survives secular pressure.
4. BZ — Kanzhun Limited · score 98
Internet Content & Information · price $13.57 · 1Y $21.28 · 5Y $18.16 · 10Y $23.18
FCF $683m C+ · Rev +12.4% B+ · D/E 0.01 A · P/E 12.8x B+ · PEG 0.17 A
Why now. Kanzhun Limited, an Internet Content & Information company, is undervalued given its 40.1% profit margin, $683m in free cash flow, and 12.8 P/E ratio. The company's 12.4% revenue growth rate and 18.2% ROE suggest a strong business model. With an analyst consensus 1-yr target of $21.28, there is potential for re-rating.
Moat. Kanzhun Limited's durable competitive advantage stems from its high 40.1% profit margin, which is driven by its ability to maintain a low 0.01 debt-to-equity ratio and generate significant free cash flow. The company's 18.2% ROE is a result of its efficient business model, which allows it to reinvest earnings and drive growth.
Risk. The main risks facing Kanzhun Limited include its 0.48 beta, which indicates a relatively low level of volatility, but also suggests that the stock may not be as resilient to market downturns. Additionally, the company's 12.8 P/E ratio is relatively low, which may indicate that the stock is undervalued, but also leaves room for multiple compression if growth slows. The 12.4% revenue growth rate may also be at risk if the company fails to maintain its competitive position.
Horizon. 1-3 yr $21.28 (analyst consensus (n=21)) — multiple re-rating thesis requires a catalyst. 5 yr $18.16 at ~6% CAGR — dividend + buyback compounding. 10 yr $23.18 if the moat survives secular pressure.
5. PRDO — Perdoceo Education Corporation · score 97
Education & Training Services · price $32.38 · 1Y $34.97 · 5Y $43.33 · 10Y $55.31
FCF $221m C · Rev +24.2% A- · D/E 0.12 A- · P/E 12.4x A- · PEG 0.72 A-
Why now. Perdoceo Education Corporation, an education and training services provider, presents a compelling value proposition with its current price of $32.38, a P/E of 12.4, and a revenue growth rate of 24.2%. The company's profit margin of 19.9% and FCF of $221m demonstrate its ability to generate cash and maintain profitability. With an analyst consensus target of $44, there is potential for significant upside.
Moat. Perdoceo Education Corporation's durable competitive advantage stems from its ability to maintain a profit margin of 19.9% and an ROE of 17.3%, indicating pricing power and efficient operations. The company's position in the education and training services sector allows it to benefit from a relatively stable demand for its services, contributing to its moat. Additionally, its debt-to-equity ratio of 0.12 suggests a conservative approach to financing, reducing the risk of financial distress.
Risk. Key risks for Perdoceo Education Corporation include its sensitivity to changes in the education sector, with a beta of 0.72 indicating some volatility. The company's revenue growth rate of 24.2% may be challenging to sustain, and any slowdown could impact its valuation. Furthermore, the lack of analyst consensus, with only 1 analyst providing a target, increases the uncertainty surrounding the company's future performance.
Horizon. 1-3 yr $34.97 (structural (no analyst coverage)) — multiple re-rating thesis requires a catalyst. 5 yr $43.33 at ~6% CAGR — dividend + buyback compounding. 10 yr $55.31 if the moat survives secular pressure.
Speculative — asymmetric upside
1. WIX — Wix.com Ltd. · score 89
Software - Infrastructure · price $56.06 · 1Y $86.75 · 5Y $112.76 · 10Y $293.41
FCF $505m C+ · Rev +13.2% B+ · D/E n/a · P/S 1.1x A- · PEG 0.12 A
Why now. Wix.com Ltd., a software infrastructure company, is currently trading at $56.06 with a 13.2% revenue growth rate and a $505m free cash flow. The company's 1.01 beta indicates a relatively stable stock price, while the $86.75 analyst consensus 1-yr target suggests a potential upside. As a spec name, Wix's growth is driven by its ability to provide website creation and hosting services to a wide range of customers, with a focus on small businesses and entrepreneurs.
Moat. Wix's moat lies in its ability to provide a user-friendly and affordable website creation platform, with a 1.1 price-to-sales ratio indicating a relatively low valuation. The company's focus on software infrastructure and its position in the spec category suggest a high-risk, high-reward investment opportunity. With a -2% profit margin, Wix is still in the process of scaling its business and achieving profitability, but its 0.12 PEG ratio indicates a potential for long-term growth.
Risk. The main risks facing Wix include intense competition in the software infrastructure sector, with a 1.01 beta indicating a relatively high level of market volatility. Additionally, the company's -2% profit margin and lack of profitability pose a significant risk to investors. Furthermore, the $54-$150 analyst target range suggests a high level of uncertainty among analysts, which could impact the stock price.
Horizon. 1-3 yr $86.75 (analyst consensus (n=20)) — catalyst-driven; binary events dominate. 5 yr $112.76 — requires the platform / technology to reach commercial scale. 10 yr $293.41 — return distribution heavily skewed.
2. BILL — BILL Holdings, Inc. · score 88
Software - Application · price $37.02 · 1Y $55.10 · 5Y $74.46 · 10Y $193.76
FCF $327m C · Rev +13.4% B+ · D/E 0.50 B · P/S 2.3x B+ · PEG 0.35 A
Why now. BILL Holdings, Inc., a software application company, is currently trading at $37.02 with a 13.4% revenue growth rate and a 0.35 PEG ratio, indicating a potential high-risk, high-reward investment opportunity. The company's free cash flow of $327m and debt-to-equity ratio of 0.5 suggest a relatively stable financial position. With an analyst consensus 1-yr target of $55.10, there may be upside potential for investors.
Moat. BILL's moat is rooted in its ability to generate $327m in free cash flow, which can be used to invest in growth initiatives or returned to shareholders. The company's 2.3 price-to-sales ratio and 0.35 PEG ratio suggest a relatively low valuation compared to its growth prospects. Additionally, BILL's 1.22 beta indicates a higher level of volatility, which may be a concern for some investors, but also presents an opportunity for those willing to take on more risk.
Risk. One of the primary risks facing BILL is its 0% profit margin, which indicates that the company is currently not generating net income. Additionally, the company's 1.22 beta and 0.5 debt-to-equity ratio suggest a higher level of volatility and potential financial risk. Furthermore, the lack of visibility into the company's ROE and analyst EPS growth rate may make it more challenging for investors to assess the company's long-term prospects.
Horizon. 1-3 yr $55.10 (analyst consensus (n=21)) — catalyst-driven; binary events dominate. 5 yr $74.46 — requires the platform / technology to reach commercial scale. 10 yr $193.76 — return distribution heavily skewed.
3. CRC — California Resources Corporation · score 88
Oil & Gas E&P · price $59.29 · 1Y $82.45 · 5Y $119.25 · 10Y $310.31
FCF $778m C+ · Rev +15.1% B+ · D/E 0.47 B · P/S 1.5x B+ · PEG 0.28 A
Why now. California Resources Corporation, an Oil & Gas E&P company, is currently trading at $59.29 with a 15.1% revenue growth rate and a 0.28 PEG ratio, indicating a potential for high growth at a relatively low price. The company has a $778m free cash flow, which could be utilized to drive further growth. As a spec company, CRC's high-risk, high-reward profile is driven by its potential to capitalize on the growing demand for oil and gas, with an analyst consensus 1-yr target of $82.45.
Moat. CRC's moat lies in its ability to generate significant free cash flow, with an FCF of $778m and a debt-to-equity ratio of 0.47, indicating a relatively stable financial position. The company's 1.5 PS ratio suggests a potential for undervaluation, given its growth prospects. Additionally, CRC's beta of 0.96 indicates a relatively low volatility, which could make it an attractive investment opportunity.
Risk. CRC faces significant risks, including a -13.4% profit margin and a -14.4% ROE, indicating potential operational inefficiencies. Furthermore, the company's 0.47 debt-to-equity ratio could become a concern if interest rates rise or the company's cash flow deteriorates. The oil and gas industry is also subject to regulatory risks and commodity price fluctuations, which could impact CRC's operations and financial performance.
Horizon. 1-3 yr $82.45 (analyst consensus (n=11)) — catalyst-driven; binary events dominate. 5 yr $119.25 — requires the platform / technology to reach commercial scale. 10 yr $310.31 — return distribution heavily skewed.
4. BHC — Bausch Health Companies Inc. · score 86
Drug Manufacturers - Specialty & Generic · price $5.36 · 1Y $7.50 · 5Y $10.78 · 10Y $28.05
FCF $989m C+ · Rev +6.7% C+ · D/E n/a · P/S 0.2x A · PEG 0.01 A
Why now. Bausch Health Companies Inc., a mid-cap specialty and generic drug manufacturer, is currently trading at $5.36 with a 6.7% revenue growth rate and a 0.2 price-to-sales ratio. The company's free cash flow of $989m and analyst consensus 1-yr target of $7.5 suggest potential for upside. BHC sells pharmaceutical products to various end markets, with a focus on specialty and generic drugs.
Moat. Bausch Health's business model is supported by its position in the specialty and generic drug sector, where companies can benefit from regulatory protection and high switching costs for customers. The company's 0.42 beta suggests a relatively stable stock price, which can be attractive to investors seeking lower volatility. Additionally, Bausch Health's profit margin of -11.5% indicates room for improvement, which could be driven by operational efficiencies and cost management.
Risk. The company faces risks related to its negative profit margin and potential challenges in improving it. Additionally, the 0.01 PEG ratio may indicate that the stock is undervalued, but it also suggests that the company's growth prospects may be limited. Furthermore, the analyst recommendation of 'hold' from 6 analysts may indicate a lack of consensus on the company's upside potential.
Horizon. 1-3 yr $7.50 (analyst consensus (n=6)) — catalyst-driven; binary events dominate. 5 yr $10.78 — requires the platform / technology to reach commercial scale. 10 yr $28.05 — return distribution heavily skewed.
5. INTA — Intapp, Inc. · score 86
Software - Application · price $23.09 · 1Y $34.57 · 5Y $46.44 · 10Y $120.85
FCF $128m C · Rev +17.1% B+ · D/E 0.06 A- · P/S 3.2x B+ · PEG 0.36 A
Why now. Intapp, Inc., a software application company, is currently trading at $23.09 with a 17.1% revenue growth rate and a 0.36 PEG ratio, indicating a potential for high growth. The company has a $128m free cash flow, which is a positive sign for its financial health. As a high-risk, high-reward stock, INTA's growth is driven by its ability to provide software solutions to its customers, and its structural catalyst is its increasing revenue growth rate.
Moat. Intapp, Inc.'s moat lies in its ability to generate a 3.2 price-to-sales ratio, which is relatively low compared to its growth rate. The company's 0.06 debt-to-equity ratio also indicates a healthy financial position, allowing it to invest in its business without significant debt burdens. Additionally, its 0.48 beta suggests a relatively low volatility compared to the market.
Risk. One of the major risks for Intapp, Inc. is its -6.5% profit margin, which indicates that the company is currently loss-making. Another risk is its -8.9% return on equity, which is a negative sign for its ability to generate profits. Furthermore, the company's 0.36 PEG ratio, while indicating high growth, also suggests that the stock may be overvalued if its growth rate slows down.
Horizon. 1-3 yr $34.57 (analyst consensus (n=7)) — catalyst-driven; binary events dominate. 5 yr $46.44 — requires the platform / technology to reach commercial scale. 10 yr $120.85 — return distribution heavily skewed.
Methodology footnote
Every pick on this list comes out of the same seven-grade quantitative model applied to every US-listed common stock with a market cap above $1B. Each pick's score breakdown is auditable from the home page — click the ticker on the rankings page to see exactly which grades and adjustments produced the number. Not investment advice. See terms for full disclosures.